Norwegian biotechnology company Hofseth BioCare piles up losses in Q4

The company ramped efforts in its consumer health division over the quarter.

Jon Olav Odegard, CFO Hofseth BioCare — Jon Olav Odegard, CFO Hofseth BioCarePhoto: Anders Furuset

Demi Korban

Published 5 February 2021, 13:21Updated 5 February 2021, 13:21

Hofseth Biocare Roger Hofseth Norway Byproducts Farmed salmon